Roger S. McIntyre, MD, FRCPC
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
Article
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder
February 26, 2015
In this article by McIntyre and colleagues, relapse rates and predictors of relapse were evaluated in 2 randomized, placebo-controlled trials of desvenlafaxine for major depressive disorder.
Article
Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care
April 15, 2014
Unlike the DSM-IV-TR, the DSM-5 allows patients with subsyndromal mixed symptoms to receive a diagnostic specifier for mixed features. Read about these diagnostic changes for bipolar disorder and their...
Article
The Risk of Developing Type 2 Diabetes Mellitus Associated With Psychotropic Drug Use in Children and Adolescents: A Retrospective Cohort Analysis
January 12, 2012
Is psychotropic drug use associated with early onset type 2 diabetes mellitus? To find out, read this article, which examines the prevalence of being prescribed antidepressant or antipsychotic medications...
